The case for immune-based approaches in biliary tract carcinoma-Reference-Cited by-同舟云学术

The case for immune-based approaches in biliary tract carcinoma

Published:2016-06-18 Issue:5 Volume:64 Page:1785-1791
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Duffy Austin G.¹,Makarova-Rusher Oxana V.¹,Greten Tim F.¹

Affiliation:

1. Gastrointestinal Malignancies Section; Thoracic-GI Oncology Branch; Center for Cancer Research, National Cancer Institute; National Institutes of Health; Bethesda MD

Funder

Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research

Publisher

Wiley

Subject

Hepatology

Reference49 articles.

1. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer;Valle;N Engl J Med,2010

2. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010

3. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

4. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011

5. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N Engl J Med

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Clinical Association Between the Inflammation-Nutritional Condition and Prognosis of Locally Advanced Intrahepatic Cholangiocarcinoma After R0 Resection: Evidence from Competing Risk and Propensity Matching Analysis;Journal of Inflammation Research;2024-05

2. Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition‐Survival Modeling Framework;Clinical Pharmacology & Therapeutics;2023-06-02

3. Immune checkpoint inhibitors in cholangiocarcinoma;Immunotherapy;2023-05

4. Integrating cytotoxic, targeted and immune therapies for cholangiocarcinoma;Journal of Hepatology;2023-03

5. Treating Biliary Tract Cancers: New Targets and Therapies;Drugs;2022-11